Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Atkuri KR, et al
Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the MHRA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Additionally, it has anti-inflammatory properties that contribute to overall health and well-being
STEP 5, the longest trial at 104 weeks, showed that weight loss was sustained over two years of continuous treatment
US$ 25.64
US$ 21.17
US$ 24.68
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
